{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:30:34Z","timestamp":1781278234205,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"am","delay-in-days":383,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["R03EY035824"],"award-info":[{"award-number":["R03EY035824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["R01029058"],"award-info":[{"award-number":["R01029058"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["DP5OD029610"],"award-info":[{"award-number":["DP5OD029610"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K12EY024225"],"award-info":[{"award-number":["K12EY024225"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY029058"],"award-info":[{"award-number":["R01EY029058"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["Ro1EY023704"],"award-info":[{"award-number":["Ro1EY023704"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01MD014850"],"award-info":[{"award-number":["R01MD014850"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["1 OT2 OD025276"],"award-info":[{"award-number":["1 OT2 OD025276"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["1 OT2 OD026555"],"award-info":[{"award-number":["1 OT2 OD026555"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["1 U24 OD023121"],"award-info":[{"award-number":["1 U24 OD023121"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["3 OT2 OD023206"],"award-info":[{"award-number":["3 OT2 OD023206"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["U24 OD023176"],"award-info":[{"award-number":["U24 OD023176"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["1 OT2 OD025277"],"award-info":[{"award-number":["1 OT2 OD025277"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["1 U24 OD023163"],"award-info":[{"award-number":["1 U24 OD023163"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["3 OT2 OD023205"],"award-info":[{"award-number":["3 OT2 OD023205"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["AOD 16037"],"award-info":[{"award-number":["AOD 16037"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","award":["HHSN 263201600085U"],"award-info":[{"award-number":["HHSN 263201600085U"]}],"id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Glaucoma"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ogla.2024.06.003","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T16:57:41Z","timestamp":1718729861000},"page":"491-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1883-9018","authenticated-orcid":false,"given":"Kiana","family":"Tavakoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5371-3483","authenticated-orcid":false,"given":"Sophia","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1322-4727","authenticated-orcid":false,"given":"Bharanidharan","family":"Radha Saseendrakumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert N.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5271-7690","authenticated-orcid":false,"given":"Sally L.","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ogla.2024.06.003_bib1","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ogla.2024.06.003_bib2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ophtha.2007.03.047","article-title":"Systemic antihypertensive medication and incident open-angle glaucoma","volume":"114","author":"M\u00fcskens","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.06.003_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1161\/HYPERTENSIONAHA.116.08068","article-title":"Antihypertensive medication postpones the onset of glaucoma: evidence from a Nationwide Study","volume":"69","author":"Horwitz","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ogla.2024.06.003_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41433-019-0603-z","article-title":"A\u00a0review of systemic medications that may modulate the risk of glaucoma","volume":"34","author":"Wu","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ogla.2024.06.003_bib5","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ophtha.2018.01.007","article-title":"Systemic medication associations with presumed advanced or uncontrolled primary open-angle glaucoma","volume":"125","author":"Zheng","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.06.003_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.ophtha.2023.05.001","article-title":"Association of systemic medication use with glaucoma and intraocular pressure","volume":"130","author":"Vergroesen","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ogla.2024.06.003_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cpt.1490","article-title":"Using healthcare databases to refine understanding of exploratory associations between drugs and progression of open-angle glaucoma","volume":"106","author":"Wang","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ogla.2024.06.003_bib8","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/jamaophthalmol.2023.3877","article-title":"Calcium channel blocker use and associated glaucoma and related traits among UK Biobank participants","volume":"141","author":"Kastner","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00129784-200707001-00003","article-title":"Calcium channel blockers: differences between subclasses","volume":"7","author":"Frishman","year":"2007","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ogla.2024.06.003_bib10","series-title":"Calcium Channel blockers","author":"McKeever","year":"2024"},{"key":"10.1016\/j.ogla.2024.06.003_bib11","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2013.10.073","article-title":"Calcium channels and their blockers in intraocular pressure and glaucoma","volume":"739","author":"Mayama","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ogla.2024.06.003_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/bjophthalmol-2014-306093","article-title":"Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells","volume":"99","author":"Quill","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269231","article-title":"Associations between healthcare utilization and access and diabetic retinopathy complications using All of Us nationwide survey data","volume":"17","author":"Chan","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2024.06.003_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.patter.2022.100570","article-title":"The All of Us Research Program: data quality, utility, and diversity","volume":"3","author":"Ramirez","year":"2022","journal-title":"Patterns"},{"key":"10.1016\/j.ogla.2024.06.003_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ajo.2021.01.008","article-title":"Predictive analytics for glaucoma using data from the All of Us research program","volume":"227","author":"Baxter","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1001\/jamaophthalmol.2022.0055","article-title":"Racial and ethnic disparities in cost-related barriers to medication adherence among patients with glaucoma enrolled in the National Institutes of Health All of Us Research Program","volume":"140","author":"Delavar","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283601","article-title":"Learning important common data elements from shared study data: the All of Us program analysis","volume":"18","author":"Mayer","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ogla.2024.06.003_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100337","article-title":"Concept coverage analysis of ophthalmic infections and trauma among the standardized medical terminologies SNOMED-CT, ICD-10-CM, and ICD-11","volume":"3","author":"Tavakoli","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ogla.2024.06.003_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2023.100391","article-title":"Advancing toward a common data model in Ophthalmology: gap analysis of general eye examination concepts to standard observational medical outcomes partnership (OMOP) concepts","volume":"3","author":"Cai","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.ogla.2024.06.003_bib20","article-title":"Heart disease and stroke statistics\u20142021 update: a report from the american heart association","author":"Virani","year":"2021143254","journal-title":"Circulation"},{"key":"10.1016\/j.ogla.2024.06.003_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/IJG.0000000000001964","article-title":"Multiple systemic vascular risk factors are associated with low-tension glaucoma","volume":"31","author":"Funk","year":"2022","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2024.06.003_bib22","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0002-9394(14)71458-8","article-title":"Calcium channel blockers in the management of low-tension and open-angle glaucoma","volume":"115","author":"Netland","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib23","first-page":"1144","article-title":"Effects of nilvadipine, a calcium antagonist, on rabbit ocular circulation and optic nerve head circulation in NTG subjects","volume":"40","author":"Tomita","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2024.06.003_bib24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00061198-199810000-00002","article-title":"The effect of nilvadipine, a calcium-channel blocker, on the hemodynamics of retrobulbar vessels in normal-tension glaucoma","volume":"7","author":"Yamamoto","year":"1998","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2024.06.003_bib25","doi-asserted-by":"crossref","first-page":"B144","DOI":"10.1016\/0002-9149(85)90623-X","article-title":"Calcium-channel blockers: effects on cerebral blood flow and potential uses for acute stroke","volume":"55","author":"Gelmers","year":"1985","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ogla.2024.06.003_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00061198-199610000-00011","article-title":"Systemic calcium channel blockers and glaucoma","volume":"5","author":"Kanellopoulos","year":"1996","journal-title":"J\u00a0Glaucoma"},{"key":"10.1016\/j.ogla.2024.06.003_bib27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.preteyeres.2010.09.002","article-title":"Use of calcium channel blockers for glaucoma","volume":"30","author":"Araie","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ogla.2024.06.003_bib28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/08164622.2021.1964332","article-title":"Mechanistic links between systemic hypertension and open angle glaucoma","volume":"105","author":"Cui","year":"2022","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ogla.2024.06.003_bib29","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/HYPERTENSIONAHA.118.11507","article-title":"Glaucoma and blood pressure","volume":"73","author":"Leeman","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ogla.2024.06.003_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1167\/iovs.63.13.3","article-title":"Blood pressure measures and incident primary open-angle glaucoma","volume":"63","author":"Macri","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ogla.2024.06.003_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ajo.2014.05.029","article-title":"The association of blood pressure and primary open-angle glaucoma: a meta-analysis","volume":"158","author":"Zhao","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ajo.2010.01.018","article-title":"Blood pressure, perfusion pressure, and glaucoma","volume":"149","author":"Caprioli","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ogla.2024.06.003_bib33","article-title":"Effect of antihypertensive medications on the risk of open-angle glaucoma","volume":"13","author":"Lee","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.ogla.2024.06.003_bib34","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1185\/03007990903035083","article-title":"Effect of selected antihypertensives, antidiabetics, statins and diuretics on adjunctive medical treatment of glaucoma: a population based study","volume":"25","author":"Iskedjian","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ogla.2024.06.003_bib35","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12913-019-4202-2","article-title":"Antihypertensive prescription among black patients without compelling indications: prescription, effectiveness, quality and cost of medication","volume":"19","author":"Akunne","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ogla.2024.06.003_bib36","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.pcad.2016.09.004","article-title":"Hypertension treatment in Blacks: discussion of the U.S. clinical practice guidelines","volume":"59","author":"Williams","year":"2016","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Ophthalmology Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962400098X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258941962400098X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T04:44:08Z","timestamp":1738125848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258941962400098X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S258941962400098X"],"URL":"https:\/\/doi.org\/10.1016\/j.ogla.2024.06.003","relation":{},"ISSN":["2589-4196"],"issn-type":[{"value":"2589-4196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Systemic Use of Calcium Channel Blockers and Incidence of Primary Open-Angle Glaucoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Glaucoma","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ogla.2024.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}